Doctors battling a rare strain of Ebola in central Africa will probably need to wait many months for a vaccine to be ready for human trials, the Coalition for Epidemic Preparedness Innovations said, underscoring the challenges health authorities face in combating the outbreak.
CEPI and its partners will start the vaccine development process immediately for multiple candidates, Chief Executive Officer Richard Hatchett said in an interview Tuesday. However, lab testing and evidence from animal trials will be needed before human studies can begin, he said. Some potential candidates have undergone initial animal testing.
“These are very, very early-stage vaccines,” Hatchett ...
